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Major immediate-early transcriptional enhancers are genetic control elements that act, through docking
with host transcription factors, as a decisive regulatory unit for efficient initiation of the productive virus
cycle. Animal models are required for studying the function of enhancers paradigmatically in host organs.
Here, we have sought to quantitatively assess the establishment, maintenance, and level of in vivo growth
of enhancerless mutants of murine cytomegalovirus in comparison with those of an enhancer-bearing
counterpart in models of the immunocompromised or immunologically immature host. Evidence is pre-
sented showing that enhancerless viruses are capable of forming restricted foci of infection but fail to grow
exponentially.
Transcriptional enhancers consist of modules of transcrip-
tion factor binding sites and mediate gene desilencing and
promoter activation in an orientation-independent manner
and even from remote sites (4). Whereas the “rheostatic”
model, also known as “rate” or “progressive-response” model,
proposes that enhancers function by increasing the rate of
transcription from a cognate gene, the “binary” model, also
known as “on-or-off” or “probability” model, proposes that
they function by raising the probability for a cognate gene
being in a desilenced state (12). In either case, the result of
enhancer action is an increased amount of transcripts. Major
immediate-early (MIE) enhancers of herpesviruses enhance
the transcription of MIE genes that encode transactivator pro-
teins critically involved in the expression of viral early-phase
(E) genes as well as host cell genes. Enhancers are therefore
regarded as key regulators for initiating the productive cycle in
acute infection as well as in the reactivation from latency. The
current knowledge of MIE enhancers of cytomegaloviruses
(CMVs), members of the beta subfamily of the herpesviruses,
and of the role of the cognate MIE proteins in the viral rep-
lication cycle have been comprehensively reviewed recently (3,
6, 26, 27, 28, 36, 42, 43). In the specific case of murine CMV
(mCMV), the MIE locus consists of a bidirectional gene pair
with a promoter-enhancer-enhancer-promoter element (8, 11,
24, 34, 40) flanked to the left and to the right by transcription
unit ie1-ie3 and gene ie2 that are transcribed in opposite di-
rections and encode the transactivator proteins IE1 and IE3 as
well as IE2, respectively (7, 21, 22, 30, 31). IE3/M122, corre-
sponding to IE2/UL122 of human CMV (hCMV), has been
identified as the essential transactivator for E gene expression
(30) and thus for viral replication (1). The two enhancer ele-
ments can act independently if engineered in isolation in vi-
ruses mCMV-Enh1 or mCMV-Enh2, and act synergistically
after infection with wild-type (WT) virus (24).
Whereas much is known from infected cell cultures, studies
of MIE enhancer function in vivo are restricted to animal
models. Accordingly, our knowledge of the in vivo role for MIE
enhancers is still incomplete. Notably, orthologous enhancers
of different CMV species can replace each other more or less
efficiently but with directional differences. Specifically, “en-
hancer swap” mutants of mCMV in which the MIE enhancer
was replaced with the hCMV MIE enhancer (2) replicated in
host organs with no obvious difference compared to WT virus
in organ and cell type tropism (15), local spread within tissues
(15), and establishment of latency as well as capability of re-
activation and recurrence (16). In contrast, the reciprocal en-
hancer swap replacing the hCMV MIE enhancer with the
mCMV MIE enhancer in a chimeric hCMV resulted in re-
duced MIE gene transcription in human fibroblast cell culture
at low multiplicities of infection (19). Likewise, the mCMV
MIE enhancer did not completely replace the rat CMV en-
hancer in cell culture and in vivo (37). The fact that the pres-
ence of an MIE enhancer is a crucial determinant of viral
replicative fitness in host organs was concluded from the com-
plete absence of detectable infectious particles and pathogen-
esis of an “enhancerless” mCMV in otherwise highly suscep-
tible immunodeficient CB17.SCID mice (13), suggesting an
absolute requirement for the MIE enhancer for virus growth in
vivo.
As already discussed in the original work by Ghazal and
colleagues (13), CB17.SCID mice, although deficient in adap-
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FIG. 1. MIE enhancer function in cultured fibroblasts. (A) Enhancement of viral transcription. BALB/c MEFs were infected under conditions
of centrifugal enhancement of infectivity with 0.2 PFU per cell of mCMV-WT.BAC (black circles) or mCMV-Enh.Luc (gray circles), resulting
in an effective MOI of 4 (25, 32). Total RNA was isolated at the indicated times after the end of the 30-min centrifugation period. Absolute
quantitation of IE1, IE3, and E1 transcripts was performed by reverse transcriptase quantitative PCR (RT-qPCR) as described in detail previously
(39), and data were normalized to 10 ng of total RNA corresponding to 1,000 cells. Symbols represent data from individual, triplicate six-well
cultures. (B) Time course of viral protein expression. Western blot analysis was performed after infection of MEFs at an MOI of 4 (see above)
essentially as described previously (18). n.i. (not infected), lysates from uninfected MEFs. Proteins IE1/m123 (23) and E1/M112-M113 (5, 10) were
detected with monoclonal antibodies (MAbs) CROMA 101 and CROMA 103, respectively (kindly provided by S. Jonjic, Rijeka, Croatia).
IE3/M122 (30) was detected with a polyclonal rabbit antiserum (kindly provided by M. Messerle, Hannover, Germany), and MCP/M86 with
affinity-purified polyclonal rabbit antibodies, custom-made as described previously (46). ACTB, -actin detected with affinity-purified polyclonal
rabbit antibody. (C) Expression and function of IE1 in individual cells. CLSM analysis was performed essentially as described and documented
previously (39, 46) for correlating ND10 numbers and levels of IE1 expression in the nuclei of the indicated numbers (n) of individual MEFs at
4 h after infection at an MOI of 4 with mCMV-IE1 (IE1, black diamonds), mCMV-Enh.Luc (Enh.Luc, dark-green diamonds), and
mCMV-WT.BAC (WT.BAC, bright-green diamonds). Horizontal and vertical dotted lines mark the median values of ND10 numbers (ordinate)
and relative IE1 fluorescein (FITC) fluorescence intensities (abscissa), respectively. The indicated P values for differences in ND10 numbers were
calculated with the nonparametric and distribution-free Kolmogorov-Smirnov test. Data sets differ significantly if the P value is0.05. (D) Imaging
of multistep virus growth in fibroblast cell cultures documenting focal spread of infection. BALB/c MEFs grown on glass coverslips in 24-well plates
were infected noncentrifugally at an MOI of 0.05 with mCMV-WT.BAC (top panels) and mCMV-Enh (bottom panels). FITC fluorescence
images were taken after IE1 (CROMA 101) staining at the indicated times after infection. The bar marker represents 200 m.
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tive immunity, are not completely devoid of innate immunity,
which might have led to an early resolution of a low-level
infection by the enhancerless virus. However, it still remains to
be determined whether the enhancerless mCMV can, in prin-
ciple, establish and disseminate a low-level maintenance infec-
tion. We therefore have here revisited the enhancer require-
ment in an even more sensitive model for detecting mCMV
replication, namely, the infection of genetically susceptible
BALB/c mice after immunoablative total-body gamma irradi-
ation, a relevant and well-established preclinical model origi-
nally designed for studying CMV infection in the context of
hematopoietic stem cell transplantation (17). Evidence is pro-
vided to conclude that enhancerless mCMV can replicate in
various host organs and spread locally to form infectious foci
for maintaining a low-level infection in the absence of expo-
nential growth.
(A part of this work is included in the M.D. thesis of R.
Pintea at the University Medical Center of the Johannes Gu-
tenberg University Mainz.)
Enhancerless virus mCMVdE::Luc, here named mCMV-
Enh.Luc, contains a luciferase gene sequence as a stuffer in
place of the mCMV MIE enhancer (13) and is based on bac-
terial artificial chromosome (BAC) plasmid pSM3fr that cor-
responds to reconstituted WT-like virus MW97.01 (45), here
named mCMV-WT.BAC. To overcome IE transactivator de-
ficiency and to eliminate attenuating BAC sequences, mCMV-
Enh.Luc was propagated, and its infectivity was quantitated
on complementing NIH 3T3-Bam cells (13).
Upon infection of noncomplementing BALB/c-derived
mouse embryo fibroblasts (MEFs) at a multiplicity of infection
(MOI) of 4 with mCMV-WT.BAC and mCMV-Enh.Luc,
steady-state levels of IE1, IE3, and E1 transcripts were found
to be reduced for the mutant by 2 log10 grades early after
infection (Fig. 1A), which was associated with reduced levels of
MIE proteins IE1 and IE3 (Fig. 1B). Interestingly, in hCMV,
GC boxes located in the proximal enhancer mediate MIE tran-
scription and viral replication in human fibroblasts through
binding of transcription factors SP-1 and/or SP-3 (20). In this
context, it is important to note that a putative SP-1 site located
at positions 93 to 102 relative to the ie1-ie3 MIE transcrip-
tion start site (1) of mCMV (24) is deleted in mCMV-
Enh.Luc (see Fig. 4A). In fact, a search for motifs by using
the MEME/MAST algorithm combined with the JASPAR da-
tabase (24) did not predict any transcription factor binding
sites between positions 1 and 47 that are retained in
FIG. 2. Virus multiplication in host organs. Throughout, symbols
indicate three to four individual mice tested for each day and group,
with the median values marked by a short horizontal bar. (A and B)
Virus multiplication in the liver of the severely immunocompromised
host. Female BALB/c mice (8 weeks old) underwent hematoablative
treatment by total-body gamma irradiation with a single dose of 7 Gy,
2 h prior to intravenous infection with mCMV-WT.BAC (black circles)
or mCMV-Enh.Luc (gray circles). (A) Virus dose dependence and
kinetics of infection. Liver tissue infection was assessed by quantitating
infected liver cells, mostly hepatocytes, in representative 10-mm2 areas
of tissue sections by IHC specific for the intranuclear proteins IE1/
m123 (for the method, see references 15 and 32) and MCP/M86 (for
the method, see reference 46), representing the IE and L phases of the
viral replicative cycle. To compensate for reduced IE1 expression after
infection with mCMV-Enh.Luc, the period of color reaction was
extended from the usual 2 min (sufficient for mCMV-WT.BAC) to 10
min. *, all mice succumbed to infection with 10
4 PFU of mCMV-
WT.BAC. (B) Multiplication of viral genomes in the liver. Viral ge-
nome numbers in the liver were quantitated at the indicated days after
infection with 103 PFU of mCMV-WT.BAC (black circles) or 106 PFU
of mCMV-Enh.Luc (gray circles) by qPCR specific for gene M55/gB
as described previously (38), using linearized plasmid pDrive_
gB_PTHrP_Tdy as the standard (41). Log-linear growth curves were
determined by regression analysis, and doubling times (DT) as well as
their 95% confidence intervals (shown in parentheses) were calculated
as explained in greater detail elsewhere (46). (C) Virus multiplication
in the immunologically immature neonatal host. Three-day-old
BALB/c pups were infected intraperitoneally with 5 	 102 PFU of
mCMV-WT.BAC (black circles) or 2 	 106 PFU of mCMV-Enh
(gray circles). At days 4 and 7 after infection, virus titers in homoge-
nates of the indicated organs were determined by PFU assay with
centrifugal enhancement of infectivity, performed on monolayers of
MIE-complementing NIH 3T3-Bam cells (16). Dotted lines indicate
the detection limit of the assay. Note that infection of pups with 5 	
104 PFU of mCMV-Enh did not yield detectable virus in any of the
organs tested (data not depicted).
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mCMV-Enh.Luc. While absence of the enhancer had little
impact on the expression of the E-phase protein E1, there
appears to be some reduction in the late (L)-phase major
capsid protein MCP/M86 (Fig. 1B), consistent with reduced
viral DNA replication and release of infectivity (24).
Expression and functional activity of protein IE1 was studied
on a single-cell level by confocal laser scanning microscopy
(CLSM) correlating nuclear IE1 fluorescence intensity and
IE1’s capacity to dissociate repressive nuclear domains 10
(ND10), as described and illustrated with images in previous
reports (14, 39, 44, 46) (Fig. 1C). Compared with mutant virus
mCMV-IE1 (14), the low level of IE1 expressed by mCMV-
Enh.Luc was able to dissociate ND10, although with a broad
overlap in the cell distributions. As expected, the high level of
IE1 expressed by mCMV-WT.BAC dissociated most ND10 in
all cells. Of importance is the observation that individual cells
infected with mCMV-Enh.Luc expressed higher levels of IE1
that were associated with efficient dissociation of ND10 and
were most likely due to a stochastically elevated basal activity
of the core promoter. In striking accordance with these data, a
FIG. 3. Focal spread of infection in liver tissue. Immunocompromised mice (see legend of Fig. 2) were infected intravenously with 103 PFU
of mCMV-WT.BAC (black bars) or 107 PFU of mCMV-Enh.Luc (gray bars). IHC specific for IE1/m123 (MAb CROMA 101) was performed
in liver tissue sections at the indicated days after infection by using the peroxidase-diaminobenzidine-nickel method for black staining (15, 32),
followed by light hematoxylin counterstaining. Data were collected and pooled from three mice per day and group. Bar diagrams show the size
distributions of 100 infectious foci counted. Caliper rules underneath the abscissas as well as representative IHC images highlight the increase in
median focus size over time. Bar markers represent 50 m.
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FIG. 4. In situ verification of virus authenticity. (A) Maps of the mCMV genome (not drawn to scale), illustrating the organization of the
mCMV MIE locus with the regulatory promoter-enhancer-enhancer-promoter (PEEP) region and the exons of the flanking IE genes as well as
the positions of the ISH DNA probes. Map positions refer to the 5 transcription start site (1) of the ie1-ie3 transcription unit, equivalent to
nucleotide 182,895 in the mCMV Smith strain genome (33) (GenBank accession no. NC_004065). Arrows indicate the DNA strand and the
divergent 5-to-3 directions of transcription for the bidirectional MIE gene pair. (B) Virus identification by two-color ISH in the coinfection
model. Immunocompromised mice were infected with 103 PFU of mCMV-WT.BAC alone, with 107 PFU of mCMV-Enh.Luc alone, or with a
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multistep growth analysis of the related mCMV-Enh
(mCMVdE with no Luc stuffer; see reference 13) in MEF
cultures revealed a low number of individual cells staining with
an intermediate brightness for IE1 and capable of forming
fluorescent foci, albeit with delayed spread compared to WT
virus (Fig. 1D). Thus, individual cells infected with enhancer-
less virus can show an almost WT phenotype with regard to
IE1 expression and function, at least in the first round of
infection, but appear to have a deficiency in replicative capac-
ity and spread. In this context, it is worth recalling that mCMV-
Enh.Luc virions were found to be poorly released into the
cell culture supernatant (24), suggesting that focus formation
may depend on cell-to-cell spread. Accordingly, we wondered
if infected host tissue cells with such a phenotype might be
founders of a progressive in vivo infection.
Since the virus dose used for infection determines the prob-
ability for successful hits, immunocompromised recipients (see
above) were infected intravenously with graded virus doses,
and infected cells in the liver, mostly hepatocytes (35), were
detected by immunohistochemistry (IHC) specific for the in-
tranuclear viral proteins IE1 and MCP (Fig. 2A). At a glance,
mCMV-Enh.Luc proved to be capable of infecting liver cells
in a log-log dose-effect relationship, but with a shift to higher
doses by 3 to 4 log10 grades. The graphs also show, however,
that the number of cells infected with mCMV-Enh.Luc did
not increase over time. This was further corroborated by mea-
suring the doubling times of viral genomes in liver tissue.
Whereas the log-linear growth curves indicate exponential
growth of mCMV-WT.BAC with a doubling time of 30 h,
mCMV-Enh.Luc barely multiplied, with no doubling in the
observation period (Fig. 2B). Importantly, these findings were
not restricted to the particular model of a severely immuno-
compromised host after hematoablative treatment, since es-
sentially the same behavior of enhancerless and WT viruses
was revealed in various organs of 3-day-old BALB/c pups rep-
resenting an immature immune system in the completely in-
dependent and likewise medically relevant model of neonatal
infection (Fig. 2C).
Stationary numbers of infected cells could reflect a nonpro-
ductive first-hit infection of cells or indicate a balance between
focal spread starting from some individual cells, as is suggested
by Fig. 1C and D, and the extinction of many others. Back to
the model of the iatrogenically immunocompromised host,
these alternatives were distinguished by measuring the size of
infectious foci in the time course by IE1-specific IHC in the
liver (Fig. 3). Clearly, at an early time, only single cells were
infected, whereas foci consisting of increasing numbers of in-
fected cells were formed with time for both viruses, although
with a faster spread of mCMV-WT.BAC. Thus, mCMV-
Enh.Luc can establish further rounds of infection in host
tissue even though the net number of infected cells increases
only slightly over time.
The fateful question remained if the observed foci really
resulted from infection with mCMV-Enh.Luc or if possibly
revertant virus was formed accidentally during virus propaga-
tion in the MIE-complementing NIH 3T3-Bam cells. Although
we could not detect the MIE enhancer sequence by quantita-
tive PCR in virus stocks of mCMV-Enh.Luc (data not
shown), minute contaminants in the high doses used for infec-
tion might have escaped detection. The identity of focus-form-
ing viruses in liver tissue sections was therefore tested most
rigorously by in situ hybridization (ISH) specific for the mCMV
MIE enhancer or the luciferase gene stuffer sequence, result-
ing in red and black staining, respectively (Fig. 4). After sep-
arate intravenous infections with either mCMV-WT.BAC or
mCMV-Enh.Luc, infectious foci present in serial 2-m sec-
tions hybridized exclusively with the cognate ISH probe. This
unequivocally demonstrated that mCMV-Enh.Luc replicated
in the absence of the MIE enhancer. Accordingly, upon intra-
venous coinfection with both viruses, distinct red and black foci
representing mCMV-WT.BAC and mCMV-Enh.Luc, re-
spectively, were detected in the same liver tissue section by
using a mixture of both ISH probes (Fig. 4B). We did not find
cases of trans-complementation through cellular coinfection,
which would have become visible by red-and-black speckled
nuclear inclusion bodies. Independent replication of both vi-
ruses is also indicated by quantitation of infected cells after
coinfection in comparison to single infections. As shown in Fig.
4C (left panel), mCMV-Enh.Luc did not profit in any way
from the presence of mCMV-WT.BAC. Interestingly, after
intraplantar coinfection with equal doses of both viruses (Fig.
4C, right panel), mCMV-WT.BAC did not help mCMV-
Enh.Luc to disseminate to the liver, which also indicated a
lack of trans-complementation. This is in striking contrast to
findings made previously for the intraplantar coinfection with
mCMV-WT.BAC and the dissemination-deficient mCMV-
M36 (9), a virus in which deletion of the antiapoptotic pro-
tein M36 prevents replication in macrophages (29). In this
example, cellular coinfection was frequent, and trans-comple-
mentation helped the mutant to travel to the liver (9). Explain-
mixture of both viruses in the 103:107 PFU ratio. ISH images of serial 2-m liver tissue sections were taken on day 10 after infection. Sections were
hybridized in a chessboard scheme with the mCMV enhancer probe (Enh probe, red staining) alone identifying cells infected with mCMV-
WT.BAC, with the luciferase gene stuffer probe (Luc probe, black staining) alone identifying cells infected with mCMV-Enh.Luc, or with a
mixture of both probes identifying both viruses simultaneously. Staining methods were described in detail previously (15, 32). Light counterstaining
was performed with hematoxylin. The bar marker represents 100 m. (C) Independent growth of the enhancerless mutant. A possible trans-
complementation of mCMV-Enh.Luc by mCMV-WT.BAC was tested by comparing single infection quantitatively with coinfection. Correspond-
ing to the experiment shown in panel B, ISH-positive cells were counted for representative 10-mm2 areas of liver tissue sections. Red and black
circles represent data from five mice per group, with the median values marked by a short horizontal bar. The dotted lines indicate the detection
limit of the assay, that is, 1 cell in 10 mm2. Statistical comparisons of interest were made with the distribution-free Wilcoxon-Mann-Whitney (rank
sum) test. P values (two-tailed) of 
0.05 indicate that there is no significant difference. The left panel shows intravenous single infection or
coinfection with 103 PFU of mCMV-WT.BAC (red) and 107 PFU of mCMV-Enh.Luc (black). The right panel shows intraplantar single infection
or coinfection with 105 PFU of either virus. (D) Organ tropism of mCMV-Enh.Luc. Corresponding to the experiment shown in panel B (lower
right ISH image), infected cells were identified with the Luc probe (black) in lung (a), adrenal gland (b1; whole organ overview section resolved
to greater detail in b2; arrows point to a particularly extended viral focus), and spleen (c). Bar markers represent 100 m throughout.
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ing this difference is an interesting issue and challenge for
future research. Finally, Fig. 4D verifies the authenticity of
enhancerless virus replicating in other organs of relevance in
CMV disease.
Conclusion. We have here revisited MIE enhancer function
and refine the previous view of its absolute requirement for
mCMV replication in vivo. Enhancerless viruses can in fact
grow independently and establish infectious foci in various
organs relevant to CMV disease. Presence of the enhancer,
however, increases the probability of initiating infection and is
required for exponential growth. The enhancer is thus a major
determinant of viral replicative fitness and pathogenicity.
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